Bacterial Vaginosis: Effects on reproduction and its therapeutics

J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102174. doi: 10.1016/j.jogoh.2021.102174. Epub 2021 Jun 2.

Abstract

Bacterial Vaginosis (BV) is the most common vaginal infection. A large amount of evidence shows that the anatomical scope of BV's pathogenic effect is far beyond the lower reproductive tract. BV is closely related to adverse reproductive outcomes, which may be due to the infection of the vaginal flora ascending to the upper genital tract. In addition, the incidence of BV is relatively high in infertile women. The vaginal microbiome also plays an important role in women's health and diseases. For most women, the normal vaginal microbiota is dominated by Lactobacillus, which can maintain a healthy vaginal environment by producing lactic acid, H2O2 and bacteriocin, etc. BV is characterized by the imbalanced vaginal flora. It changes the acidic environment that is normally dominated by Lactobacillus, and causes an overgrowth of anaerobic and facultative anaerobic bacteria such as Gardnerella vaginalis and Atopobium vaginae. Studies have shown that bacterial infections in the vagina can spread to upper genital tract and cause adverse fertility outcome. Therefore, early diagnosis and therapeutics of symptomatic BV is helpful to improve the outcome of poor fertility.

Keywords: Bacterial Vaginosis; Biofilm; Lactobacillus; Reproduction; Therapeutics.

Publication types

  • Review

MeSH terms

  • Adult
  • Female
  • Humans
  • Reproductive Health / standards*
  • Reproductive Health / statistics & numerical data
  • Treatment Outcome
  • Vagina / drug effects
  • Vagina / microbiology
  • Vaginosis, Bacterial / complications*